Lv1
64 积分 2025-11-25 加入
Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial. Lancet Gastroenterol Hepatol
1个月前
已完结
Reticulate Hyperpigmentation Secondary to Chemotherapy Combining Gemcitabine and Cisplatin
1个月前
已完结
An Open-label, Multicenter, Single-arm, Phase II Study of Fluzoparib in Patients with Germline BRCA1/2 Mutation and Platinum-sensitive Recurrent Ovarian Cancer
1个月前
已完结
Diagnosis and management of immune checkpoint inhibitor-associated acute kidney injury
1个月前
已完结
Nail toxicity associated with anticancer agents
1个月前
已完结
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial
2个月前
已完结
First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations
2个月前
已完结
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer
2个月前
已完结
An Open-label, Multicenter, Single-arm, Phase II Study of Fluzoparib in Patients with Germline BRCA1/2 Mutation and Platinum-sensitive Recurrent Ovarian Cancer
3个月前
已完结
Synergistic interactions and optimal sequencing of chemotherapy and immunotherapy in cancer treatment
4个月前
已完结
皖公网安备34019202002308
